2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$94.98-$0.09 (-0.09%)
Price as of Oct 22, 2026 7:49 PM EDT- $20.5BMarket Cap
- -40.63%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$94.98-$0.09 (-0.09%)
INSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $95.06 | ||
Change | -$1.63 (-1.70%) | ||
Open | $93.50 | ||
High | $95.59 | ||
Low | $93.33 | ||
Previous Close | $94.04 | ||
Volume | 3,099,799 | ||
30-Day Average Volume | 2,814,037 | ||
1-Week Change | -3.83% | ||
1-Month Change | -22.28% | ||
1-Year Change | -41.37% | ||
3-Year Change | 274.96% | ||
5-Year Change | 241.72% | ||
Fundamentals | |||
Shares Outstanding | 218.4M | ||
Total Assets | $2.1B | ||
Market Cap | $20.5B | ||
Enterprise Value | $20.5B | ||
Period: QTR TTM FY | |||
Revenue | $425.5M | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$95.1M | ||
EBIT | -$11.4M | ||
EBITDA | -$9.3M | ||
Net Working Capital | $1.2B | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -2,210 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 27 | ||
P/E | -1,567 | ||
PEG | -17 | ||
Price/Free Cash Flow | -216 | ||
Price/Operating Cash Flow | -231 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/03/2011 | ||
Earnings & Revenue